AKT1 and diabetic kidney disease: Interestingly, a recent study conducted in mice with diabetic nephropathy showed that butyrate can reduce skeletal muscle atrophy in diabetic nephropathy by stimulating the FFA2-mediated PI3K/AKT/mTOR signaling pathway [26].